Abstract:Screening diagnostic biomarkers can be challenging due to the complexity of traditional Chinese medicine (TCM) and ambiguous pharmacological mechanisms. In this study, we reported an integrated strategy for accurately screening diagnostic biomarkers based on metabolomics coupled with network pharmacology. First, a feasible pharmacological model was established through systems pharmacology and based on metabolomics-based techniques to explore diagnostic biomarkers. While the components satisfying the q-value < 0.05, fold change (FC) ≥ 1.2 or FC ≤ 0.8, coefficient of variance (CV) ≤ 30%(QC) and the variable importance in the project (VIP) value > 1 are considered to be diagnostic biomarkers. Second, the ingredients were retained only when oral bioavailability (OB), Caco-2 permeability, drug half-life, TPSA and drug likeness (DL) satisfied the criteria (OB ≥ 40%; Caco-2 ≥ -0.4; HL ≥ 4 h; TPSA˂140; DL ≥ 0.18) suggested by the TCMSP database. Moreover, ingredients that exhibit extensive biological activity in TCM are also retained. Third, the effect targets of TCM were screened using the TCMSP database, Swiss Target Prediction and STICH online software. Disease targets were gathered from the therapeutic target database (TTD), PharmGkb and TCMSP database. Hub genes were screened by potential protein-protein interaction (PPI) network pharmacology analysis. Finally, a metabolic network pathway is established between the diagnostic biomarker and the hub gene. In the network analysis of metabolic pathways, most of the genes involved in this pathway are the second-step-obtained hub genes, which can explain the accuracy of the identified biomarkers. The proposed integrated strategy was successfully applied to explore the mechanism of action of Pulsatilla decoction (PD) in the treatment of acute ulcerative colitis (UC). Based on this integrated strategy, 23 potential biomarkers of acute UC treated with PD were identified. In conclusion, the integrated strategy provides novel insights into network pharmacology and metabolomics as effective tools to illuminate the mechanism of action of TCM.

Evaluation of the "Multi-Efficacy of One Drug" of Traditional Chinese medicines Based on the Biological Target Network: Towards Precision Medicine

Network pharmacology approaches for research of Traditional Chinese Medicines

Database of traditional Chinese medicine and its application to studies of mechanism and to prescription validation.

Evaluation of Therapeutic Effects of TCM Based on Metabolic Variations

Network Pharmacology Evaluation Method Guidance - Draft

Enhancing Clinical Efficacy Through the Gut Microbiota: A New Field of Traditional Chinese Medicine

Network Pharmacology Databases for Traditional Chinese Medicine: Review and Assessment

Traditional Chinese Medicine Network Pharmacology: Theory, Methodology and Application.

Chinmedomics: a potent tool for the evaluation of traditional Chinese medicine efficacy and identification of its active components

Metabolomics and Its Application to the Evaluation of the Efficacy and Toxicity of Traditional Chinese Herb Medicines.

TCM Network Pharmacology: A New Trend Towards Combining Computational, Experimental and Clinical Approaches

A systems-pharmacology analysis of herbal medicines used in health improvement treatment: predicting potential new drugs and targets.

SYSTCM: A systemic web platform for objective identification of pharmacological effects based on interplay of "traditional Chinese Medicine-components-targets"

Advances in Methods of Predicting and Discovering Targets of Traditional Chinese Medicine

Application of Evaluation of Multiple Primary Endpoints Based on Combination of Diseases and Symptoms in TCM Clinical Trials

[Network Target: a Starting Point for Traditional Chinese Medicine Network Pharmacology].

Metabolomics Highlights Pharmacological Bioactivity and Biochemical Mechanism of Traditional Chinese Medicine

Multi-omics approaches for in-depth understanding of therapeutic mechanism for Traditional Chinese Medicine

Integrated strategy for accurately screening biomarkers based on metabolomics coupled with network pharmacology

Network Pharmacology for Traditional Chinese Medicine Research: Methodologies and Applications